Clinical TrialID 856
Effects of Berries and Berry Fractions on Metabolic Diseases
NCT01860547
Type 2 Diabetes|Atherosclerosis
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Trial: 1Herb: 1Links: 1
Arranging relationship network...
Record Fields
Scalar fields from the final clinical_trial record.
- Clinical Trial Id
- 856
- Evidence Id
- 856
- Core Evidence Id
- 856
- Source Clinical Trial Id
- 838
- Herb2 Clinical Trial Id
- HBCT000838
- Nct Id
- NCT01860547
- Title
- Effects of Berries and Berry Fractions on Metabolic Diseases
- Status
- Completed
- Phase
- Study Result
- No
- Study Condition
- Type 2 Diabetes|Atherosclerosis
- Study Type
- Interventional
- Study Design
- Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: PREVENTION
- Intervention
- DIETARY_SUPPLEMENT: Bilberries|DIETARY_SUPPLEMENT: Sea buckthorn berry|DIETARY_SUPPLEMENT: Sea buckthorn phenolic extract|DIETARY_SUPPLEMENT: Sea buckthorn oil
- Intervention Allocation
- Randomized
- Intervention Model
- Crossover
- Intervention Mask
- Intervention Purpose
- Prevention
- Gender
- Female
- Age
- Adult
- Enrollment
- 110
- Outcome Measure
- Serum Alanine aminotransferase (ALAT), Change from beginnig to end of each berry treatment (duration of treatments average 33-35 days)
- Sponsor Collaborator
- University of Turku|Pakkasmarja|Saarioinen|Kiantama Ltd.|Aromtech Ltd.|Fazer|Satakunta Sea Buckthorn Society|Finnish Berry Powders Ltd.
- Funded By
- OTHER
- Location
- University of Turku, Dept of Biochemistry and Food Chemistry, Turku, FI-20014, Finland
- Other Id
- TYBID1
- Start Date
- 2008-06
- Primary Completion Date
- 2009-06
- Completion Date
- 2009-08
- First Posted
- 2013-05-22
- Results First Posted
- Last Update Posted
- 2013-05-22
- Study Document
- Study Url
- https://clinicaltrials.gov/study/NCT01860547
- Title Cn
- Title En
- Effects of Berries and Berry Fractions on Metabolic Diseases
- Bilingual Status
- semi_complete